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Abstract
Motivation: Existing methods for estimating copy number variations in array comparative genomic hybridization (aCGH) data are 
limited to estimations of the gain/loss of chromosome regions for single sample analysis. We propose the linear-median method for 
  estimating shared copy numbers in DNA sequences across multiple samples, demonstrate its operating characteristics through simula-
tions and applications to real cancer data, and compare it to two existing methods.
Results: Our proposed linear-median method has the power to estimate common changes that appear at isolated single probe positions 
or very short regions. Such changes are hard to detect by current methods. This new method shows a higher rate of true positives and a 
lower rate of false positives. The linear-median method is non-parametric and hence is more robust in estimating copy number. Addi-
tionally the linear-median method is easily computable for practical aCGH data sets compared to other copy number estimation 
methods.
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During cell division, a cell replicates its genome by 
synthesizing a new copy of each chromosome, using 
the original DNA as a template. The expected copy 
number of 2, may be less/greater than 2 when altera-
tions occur during the replication process. Research 
has suggested that such abnormalities in the number 
of DNA copies in a cell are associated with the devel-
opment and progression of disease, including cancer.1 
Laboratory  research  to  estimate  the  altered  copy 
  numbers in a DNA sequence often uses aCGH. The 
technology  used  to  produce  aCGH  data,  however, 
may result in data that contain uncontrollable noise.2 
The use of appropriate statistical methods to normal-
ize  the  data  and  produce  meaningful  estimates  of 
copy number variation in a DNA sequence is integral 
to  this  research.  Developing  improved  statistical 
methods  for  this  application  is  the  focus  of  this 
paper.
Different statistical methods have been suggested 
for use with aCGH data to estimate copy numbers 
in DNA sequences. Methods to analyze copy num-
bers in terms of identifying the locations of gains or 
losses of chromosome regions have been developed. 
Assuming that there is a connection between copy 
number changes in a cancer cell and the develop-
ment/progression of the cancer, there must exist some 
common change regions in DNA sequences collected 
from different patients with the same cancer   diagnosis. 
Techniques for analyzing shared copy number regions 
have been developed.3,4 For detecting copy number 
regions  in  a  single  sample,  Olshen  et  al5  and 
  Venkatraman  et  al6  had  developed  a  widely  used 
method,  the  faster  circular  binary  segmentation 
(CBS)  method.  In  this  paper,  we  propose  a  new 
method,  the  linear-median  method,  for  estimating 
shared copy number alterations in DNA sequences 
collected from the same type of cancer cells. The 
linear-median method is able to optimally use the 
information  available  across  independent  DNA 
sequences.
This paper is organized as follows. In Section 2.1, 
we discuss current existing statistical models used to 
assess aCGH data and describe a new model for ana-
lyzing  multiple  independent  aCGH  data  sets.  We 
introduce the linear-median method in Section 2.2. In 
Section 3.1, we present three simulation studies. We 
study how much extra information on copy number 
aberration can be obtained by using the linear-median 
method  compared  to  the  comparative  genomic 
  hybridization  minimal  common  region  (cghMCR) 
method  and  the  CBS  algorithm.  We  present  an 
  application of the linear-median method to real data 
in Section 3.2. Supporting figures and tables are avail-
able online as Supplementary Material.
2. Methods
2.1. Modeling DNA copy number  
alterations in aCGh data
aCGH  employs  the  comparative  hybridization  of 
genomic DNA that is differentially labeled according 
to its source in a cancer cell versus a normal cell. The 
ratio of the hybridization intensities along the chro-
mosomes  provides  a  measure  of  the  relative  copy 
number of sequences in the genomes that hybridize to 
each location on the chromosomes. Estimating copy 
numbers and identifying the locations of gains and 
losses in a DNA sequence are two main challenges in 
the  analysis  of  aCGH  data.  We  label  the  normal 
genomic  sequences  as  “reference”  sample  and  the 
genomic sequences from cancer cells as the “test” 
sample. Let Tp denote the “test” copy number at probe 
position p and Rp denote the “reference” copy number 
at probe position p.
We  briefly  describe  two  current  methods  for 
  modeling aCGH data. Let us denote by Yp the aCGH 
data (the logarithm intensity ratio) observed at probe 
position p.
Model 1: Y p = log2(Tp/Rp) + εp,  (1)
where εp are i.i.d. with normal distribution N(, ). 0
2 σ ε  
This Gaussian model forms the basis of many models 
for aCGH data.4,6–8
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where εp and ηp are i.i.d with a normal distribution 
N(0,σ2).9,10
In practice, Rp is assumed to be 2. Given the loga-
rithm intensity ratio observations, {Yp}, we want to 
estimate the true copy number at position p or to esti-
mate if the copy number at p is greater/less than 2.
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structures to describe the system. The variance of the 
log intensity ratios given by Model 1 is a constant, 
whereas the variance of the log intensity ratios given 
by Model 2 is a function of Tp.
We consider which of the two models is a more 
appropriate  model  for  the  analysis  of  aCGH  data. 
Although Model 1 looks simpler, it is not an appropri-
ate model for aCGH data. The main reason for this is 
that aCGH data provide the ratio of the copy   number 
variations, not the ratio of the copy numbers. Further-
more, empirical studies show that the standard error 
of the logarithm of the intensity ratios increases as the 
copy number increases. Additionally, the distribution 
of the logarithm of intensity ratios is skewed.9 Thus, 
the distribution of εp should not be assumed to be nor-
mal if Model 1 is adopted.
Compared to Model 1, Model 2 is a more appro-
priate model for aCGH data, as it takes into account 
the ratio of the copy number variations. However, 
this model can be improved further. The normality 
assumptions  on  the  distributions  of  εp  and  ηp  can 
imply that negative values of εp and ηp will lead to 
log2 (Tp + ε/2 + η) being ill-defined. Theoretically, 
this  will  cause  problems  for  statistical  inference 
  methods based on such an assumption.
In Model 2, the errors εp and ηp play the role of 
  measurement errors. Given the fact that the aCGH tech-
nique is maturing, it might be reasonable to suggest that 
both εp and ηp follow a uniform distribution U(-a, a), 
where a can assume any value between 0 and 2, depend-
ing on the nature of the underlying aCGH technique. If 
a takes a value close to 2, this may mean that the under-
lying aCGH technique is not very accurate, possibly 
leading to a very large variation in the observations of 
the intensity ratios. If a takes a value close to 0, we may 
assume that the underlying aCGH technique is very 
accurate and that there is less variation in the observa-
tions of the   intensity ratios. For explicit technical con-
siderations see wikipedia.2 For our purpose, we restrict 
a to be less than 2. We apply this restriction to real data 
analysis in Section 3.2. The output of the real data anal-
ysis shows the restriction is acceptable.
Therefore, we consider a third model:
Model 3:  X
T
R
p
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pp
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,  (3)
where εp and ηp are independent and have uniform 
distribution U(-a, a) with constant a ∈ (0, 2), and Xp 
is the observed intensity ratio at probe position p.
To allow the model to be more flexible, we can 
assume that the uniform distributions for εp and ηp are 
not necessarily the same.
Model 3 is used to model one aCGH profile from 
one sample/patient. However, if there is a group of 
independent  samples  of  aCGH  data  (eg,  multiple 
patients) and their data share copy number change 
regions, we can extend Model 3 to such data.
Consider  the  following  scenario.  A  group  of  n 
patients  suffer  from  a  common  cancer.  For  each 
patient a sample of aCGH data is collected from a 
cancer cell. Let Xi,p be the observed intensity ratio for 
the ith sample at probe position p. We use tp to denote 
the theoretical true value of the shared copy number 
at probe position p for the “test” and let Ti,p be the true 
copy number for the ith patient at probe position p. 
Ti,p is not necessarily equal to tp because, for different 
patients,  the  copy  number  at  position  p  might  be 
affected by different uncontrollable random factors. 
We use Tp to denote the observed copy number for 
“test” at position p. Tp is a random variable and Ti,p is 
a sample from Tp. Let Ri,p be the true copy number for 
the ith “reference” at the position p. In this paper, we 
always assign Ri,p = 2 because the true copy number 
for the reference (normal) genome is 2 (For the pur-
pose of this study we ignore some special cases).
For multiple independent aCGH data, the extended 
model can be considered as
Model 4
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where M is the total number of probe positions; n is 
the number of independent samples in the group; εi,p 
and ηi,p are mutually independent random   variables; 
Ti,p has distribution P(Ti,p = tp) = π and P(Ti,p = 2) = 1–π, 
if tp ≠ 2, ie, if at probe position p the shared true copy 
number is not 2, then the copy   number given by the 
ith sample at the probe position will follow a Ber-
noulli distribution with mean π; εi,p and ηi,p will have 
uniform distributions U(-a,a), as defined in Model 3. 
(Different uniform distributions are allowed for εi,p 
and ηi,p; however, such applications are beyond the 
scope of this paper.)
The linear-median method
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independent  aCGH  data  in  terms  of  the  following 
arguments:
i.  The  probability  distributions  of  εi,p  and  ηi,p  are 
allowed to be different. This means that the prob-
ability distribution of the measurement errors for 
the  “test”  and  “reference”  are  allowed  to  be 
different.
ii. The true shared copy number at position p is no lon-
ger a constant. Tp is a random variable. This means 
that the copy number (if it were observable) at posi-
tion p could be different from patient to patient.
Hereafter,  we  consider  multiple  independent 
aCGH  data  and  assume  Model  4  as  the  basis  for 
developing  a  method  to  estimate  the  shared  copy 
number tp, p = 1, ⋅⋅⋅, M.
2.2. The linear-median method
Currently, all raw data used for copy number analysis 
are presented in the format of a log2 intensity of the 
ratios of the test to the reference. From the current 
literature, we know that a linear format refers to using 
the intensity of the ratios of the test to the reference, 
and a nonlinear format refers to using a log2 intensity 
of  the  ratios  of  the  test  to  the  reference,  as  the 
log2(ratio) is not linearly related to the copy number. 
The variance of a linear format tends to be larger than 
the variance of a nonlinear format when the relative 
copy number is far away from 1.11 This may explain 
why the nonlinear format is widely used.
It is expected that the log2 of the true relative 
copy number, ie, log2 (tp /Rp), can be well estimated 
using the observations of the log2 intensity of the 
ratios of the test to the reference, ie, log2 [(Ti,p+ εi,p)/
(Ri,p+ηi,p  )], through the sample mean. Unfortunately, 
this is generally not true. A simple reason for this is 
that, in general,
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Further, the probability distribution of log2 [(Tp+ εp)/
(Rp+ ηp   )]  is  not  symmetric.  Therefore,  the  sample 
mean  of  log2 [(Ti,p+ εi,p)/(Ri,p+ ηi,p)]  might  be  biased 
from E [log2 ((Tp+εp)/(Rp+ηp))] for smaller   samples. 
Figure 1 shows a histogram of simulated data drawn 
from the population log2 [(1 + ε)/(2 + η)], with ε and η 
i.i.d. uniformly distributed U(-1.8, 1.8) (the function 
will not be defined if 1 + ε # 0).
For the estimating procedure we propose, we will 
use linear format data rather than nonlinear format 
data  to  estimate  the  shared  copy  number  at  probe 
position p, 0 # p # M.
As defined in Model 4, Xi,p is a random variable of 
the intensity of the ratios of the test to the reference 
given by the ith sample at probe position p, 1 # p # M, 
and satisfies the model
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where i denotes the ith sample/patient; εi,p and ηi,p are 
i.i.d. with uniform distribution U(-a, a); Ti,p and Ri,p 
are the test intensity and reference intensity, respec-
tively, for probe p for the ith sample.
As stated in Section 2.2, we always assign Ri,p = 2, 
which is the information given by the “reference” 
genome. The true shared copy number tp at position p 
needs to be estimated. The estimate of tp is denoted by 
tˆ
p,1 # p # M.
Let xi,p be the observed values of Xi,p, i = 1, 2, ⋅⋅⋅, n, 
p = 1, ⋅⋅⋅, M. Herein, we assume that parameter a is 
unknown  but  has  a  value  within  (0,  2)  and  that 
parameter π (defined in Model 4) is known or can be 
estimated from empirical knowledge.
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Figure 1. Histogram of log2 [(1 + ε )/(2 + η)].
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steps:
Step 1 Calculate the median of {xi,p} i = 1,2, ... ,n for each 
p, denoted by Mp.
Step 2 Calculate 2(Mp-1 + π)/π for each p.
Step 3 Determine the estimate of tp, p = 1, ⋅⋅⋅, M,
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where  [c]  denotes  the  integer  part  of  the  real 
number c.
We  call  this  3-step  method  the  “linear-median 
method”. “Linear” indicates that the data (the inten-
sity of the ratios of the test to the reference) are in a 
linear format. “Median” indicates that the median of 
the data is employed by this method.
Next, we explain theoretically why copy num-
bers  can  be  accurately  estimated  by  this  3-step 
method.
Let Xp be the intensity of the ratios of the test to the 
reference at probe position p,
X
T
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,
where εp and ηp are i.i.d. with uniform distribution 
U[-a, a]; and Tp is a random variable independent of 
εp and ηp, and has distribution P(Tp = tp) = π and 
P(Tp = 2) = 1 - π, if the shared copy number tp ≠ 2. As 
explained in Section 2.1, we assume 0 , a , 2.
Following the definition of Xp and assuming the 
independence of Tp + εp and ηp, we have
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Equation (5) gives the exact relationship between 
tp and E(Xp). For each probe position p, if the mean of 
the intensity of the ratios of the test to the reference is 
known, and the system parameters a and π are known, 
the shared copy number at the probe position can be 
correctly identified.
However, E(Xp) is unknown in practice and the 
probability distribution of Xp is not usually   symmetric. 
It  is  inappropriate  to  estimate  E(Xp)  by  using  the 
  sample mean X p when the sample size is not appro-
priately large. Therefore, it is difficult to evaluate tp 
directly from (5) in practice.
To overcome this difficulty, we suggest the fol-
lowing way to evaluate tp:
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where  mX p  is  the  median  of  Xp.  It  is  technically 
  possible to directly evaluate the ratio
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and prove that the ratio is close to 1, for any a ∈   
(0, 2) and any π ∈ (0, 1).
The linear-median method
Cancer Informatics 2010:9  233We use the Monte Carlo method to indirectly show 
that the value of (6) is close to 1 for a = 0.1, 0.2, ⋅⋅⋅, 
1.9  and  π  =  0.1,  0.2,  ⋅⋅⋅,  1.  (see  Appendix  A  and 
  Supplementary Tables 1 and 2 in the online materials 
for details). Therefore,
t
m
p
X p ≈
-- 21 (( ))
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π
π
3. Implementation and results
3.1. Simulation studies
The linear-median method is designed for estimating 
shared copy number aberrations and mainly focuses 
on the information across the sample for each probe 
position. Therefore, this method ignores the depen-
dency within each individual sample. Our focus is 
two-fold: i) to determine the extent of information of 
shared copy number aberrations that can be detected, 
regardless  of  the  impact  of  dependency,  and  ii)  to 
assess the differences in detection outcomes obtained 
from the linear-median method versus other methods.
In  a  recent  review  of  methods  for  detecting 
  “recurrent” copy number alterations, Rueda and Diaz-
Uriarte  evaluated  the  CGHregions  method,  Master 
HMMs, cghMCR, GISTIC, MSA, RAE, and others.12 
In  this  subsection,  we  compare  the  linear-median 
method  to  the  cghMCR  method  and  the  CBS 
method.
We present three simulation studies to highlight the 
performance of our proposed linear-median method.
Example 1: A sequence of integers
22222222223333333333
23333333332222222222
1111122222333334444 44
55555222222222233333
11111333332222222222
“test” at probe position 1 is 2; t11 = 3 means that the 
true gain in the shared copy number by the “test” at 
probe position 11 is 3.
We simulated a group of independent realizations 
{Xi,p} from model (tp + εi,p   )/(2+ηi,p   ), p = 1, 2, ⋅⋅⋅, 100 
and i = 1, 2, ⋅⋅⋅, n, where εi,p and ηi,p are i.i.d. with uniform 
distribution U[-a, a].
Subsequently, we generated 1000 replicates. For 
the kth replicate, k = 1, 2, ⋅⋅⋅, 1000, let d(k) be the per-
centage of tp - t�
p ≠ 0 out of the 100 probe positions; 
d(k) is used to measure the error rate in the estimation 
of tp. The mean and standard error of {d(k)} are pre-
sented in Table 1.
Table 1 shows that the error rate increases with a. 
This is obvious because a larger value of a is equiva-
lent to a larger measurement error in the data. How-
ever, the error rate will be reduced when the number 
of  independent  samples  in  the  group  increases.  In 
general, the mean error rate calculated for the linear-
median method is reasonably low: the mean error rate 
was less than 10%, as expected, for all three cases of 
varying a.
Although  the  underlying  model  involves  the 
parameter a, Example 1 shows, in general, that the 
impact of the value of a on the estimation of the copy 
number is not significant in terms of the mean of d(k), 
except  for  a  very  large  value  of  a(.1).  (Further 
  demonstrations are presented in the Supplementary 
Material.) In summary, the value of a ∈ (0, 2) has 
minimal effect on the estimation of the shared copy 
number when the sample size is reasonable large. As 
a result, the linear-median method can be employed 
without knowing the value of a, as long as a ∈ (0, 2).
serves  as  a  sequence  of  the  true  shared  copy 
  number  tp,  p  =  1,  2,  ⋅⋅⋅,  100,  obtained  from  the 
experimental sample, ie, the “test”. To simplify, 
we assume π = 1. Thus, for example, t1 = 2 means 
that the true shared copy number shown by the 
Example 2: In Table 1 of their review of 15 esti-
mation  methods,  Rueda  and  Diaz-Uriarte  indicate 
that only the cghMCR method both uses an input of 
the  log2  ratio  and  produces  estimations  of  the 
  differences in the states of two successive probes.12 
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  minimal  common  copy  number  alteration  regions 
among  a  group  of  independent  samples;  thus  it  is 
analogous  to  the  linear-median  method  and  is  an 
appropriate method to compare to the linear-median 
method. Using segmented data (ie, smoothed data), 
the cghMCR algorithm first identifies altered   segments 
within each subject (those above the 97th or below 
the 3rd percentile of the data) and then joins adjacent 
segments separated by a user-defined parameter. The 
R package for the cghMCR method is available at the 
following URL: http://www.bioconductor.org/packages/ 
2.6/bioc/html/cghMCR.html. See the work of   Aguirre 
et al for explicit details and a complete review of the 
cghMCR method.3
We use simulated data to compare the performance 
of the linear-median method to that of the cghMCR 
method. The data were simulated by assuming non 
dependency between the intensity ratios across probe 
positions, which is a very simple situation.
Consider a sequence of true shared copy number 
{tp} plotted in Figure 2.
The sequence tp consists of four abnormal shared 
copy number regions, corresponding to copy numbers 
1, 3, 4 and 5. Some of the abnormal shared copy 
regions are very short, involving only 1 or 4 probe 
positions. Using this example, we compare the linear-
median method to the cghMCR method in terms of 
each methods’ capability of correctly assessing the 
information of gains/losses in shared copy numbers.
We simulated data from the following model
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i = 1, 2, ⋅⋅⋅, n, where εi,p and ηi,p are i.i.d. with uni-
form distribution U(-a, a). Let B(1, π) be a random 
variable  with  a  Bernoulli  distribution  such  that 
E[B(1, π)] = π. We considered 3 × 5 × 3 different 
combinations for (a, π, n), where a = 0.5, 1, 1.5, 
π = 0.2, 0.4, 0.6, 0.8, 1 and n = 20, 50, 100.
We applied the linear-median method and the cgh-
MCR method to each group of independent samples 
with size n for different pairs of parameters (a, π), 
Table 1. The sample mean and sample standard error of 
the estimated error rate {d(k)} given by different combina-
tions of a and n, where a is the parameter of the uniform 
distribution U[-a, a] and n is the number of the indepen-
dent sequences in the realizations.
a n
25 50 75
0.5 0.00267 
(0.00505932)
0.00021 
(0.00143456)
0.00003 
(0.00054717)
0.8 0.03080 
(0.01634096)
0.00578 
(0.00725564)
0.00566 
(0.01330000)
1 0.06900 
(0.02388243)
0.01822 
(0.01335702)
0.00771 
(0.00880531)
1.5 0.19759 
(0.03871163)
0.08208 
(0.02652880)
0.04332 
(0.02063500)
1.9 0.30161 
(0.04409140)
0.15426 
(0.03687835)
0.09367 
(0.02802528)
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Figure 2. Plot of the sequence of the true copy numbers.
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Cancer Informatics 2010:9  235respectively.  Then,  for  each  triplet  (a,  π,  n),  we 
calculated the true positive (TP) rates and the false 
positive  (FP)  rates  produced  by  each  model.  TP 
rate = P(the method shows “copy number changed” 
| copy number is changed). FP rate = P(the method 
shows “copy number changed” | copy number is not 
changed). The linear-median method is able to pro-
vide an estimate of the shared copy number at each 
probe position. Therefore, when we say that a correct 
detection of the shared copy number was produced 
by the linear-  median method at position p, it means 
that t
^
p = tp. In contrast, the cghMCR method provides 
information on only the shared copy number gain/
loss at each probe position. It does not provide infor-
mation on how many copy numbers were gained/lost. 
Therefore, when we say that a correct detection was 
produced by the cghMCR method at position p, it 
means only that a gain/loss was correctly identified at 
position p.
Finally, we carried out 250 replicates for the case 
where n = 20; 100 replicates for the case where n = 50, 
and 50 replicates for the case where n = 100. The 
resulting TP and FP rates, means, and standard errors 
obtained from both methods are shown in Supple-
mentary Tables 3–5.
In terms of the TP rates, the linear-median method 
worked  reasonably  well  in  each  case  and  per-
formed vastly better than the cghMCR method, which 
showed poor performance, especially when a was 
larger and π was smaller. In this particular example 
of a true shared copy number sequence, the cghMCR 
method tended to give a lower FP value, ie, it did not 
call as many gains/losses, and hence was very con-
servative.  Compared  to  the  cghMCR  method,  the 
linear-median method gave a lower FP value when a 
was not close to 2 or π was greater than 0.5. In sum-
mary,  two  advantages  of  using  the  linear-median 
method include:
1. The ability to estimate the actual shared copy num-
ber at each position p. The estimation accuracy of 
the linear-median method is very high, as reflected 
by the values of the TP and FP rates.
2.  Better  power  in  identifying  shorter  alternating 
regions. For example, considering the data simu-
lated from (7) with a = 1.5, π = 1 and n = 20, we 
can compare the means of the estimated copy num-
bers given by both methods. Since a = 1.5, the 
variance for U(-a, a) is relatively large and the 
simulated data involve a lot of random noise. By 
choosing π = 1, there is no variation on the true 
copy numbers shared across the independent sam-
ples. Technically, one expects that the linear-me-
dian method and the cghMCR method will perform 
at the same level. However, it turns out that the 
linear-median  method  dominates  the  cghMCR 
method. At almost every probe position, the sam-
ple mean and median of the estimated shared copy 
number given by the linear-median method was 
the same as the true shared copy number. In con-
trast, the cghMCR method did not accurately iden-
tify  the  gain/loss  regions  (see  Supplementary 
Figures 1–3).
This simulation example (Example 2) illustrates 
that the cghMCR method performs very poorly in 
high-noise scenarios, for example, a  =  1.5,  and 
the cghMCR method is not robust for large values 
of a. We believe this is due to the fact that the cgh-
MCR method performs segmentation and calling 
functions independently of one other; whereas the 
linear-median  method  borrows  strength  from  all 
the samples.
Example 3: In this example we consider data Xi,p, 
simulated from the following model:
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[–1, 1], i = 1, 2, ⋅⋅⋅ 60. In this example we continue to 
assume π = 1. The abnormal copy number regions are 
[101, 150] for tp = 3; [151, 152] for tp = 4; [153, 200] 
for tp = 3; [201, 202] and [205, 300] for tp = 1.   Segments 
of [101, 150], [153, 200] and [205, 300] are relatively 
longer. Segments of [151, 152] and [201, 202] are 
  relatively shorter.
In  this  example,  we  compare  the  linear-median 
method  to  the  circular  binary  segmentation  (CBS) 
method, which was developed by Olshen et al.6 An R 
package description for the CBS method is available  at 
the following URL: http://bioconductor. org/packages/ 
2.6/bioc/manuals/DNAcopy/man/DNAcopy.pdf. The 
CBS method is employed to find segments along the 
chromosome that share constant DNA copy numbers. 
Technically, it is inappropriate to directly compare 
the  analytical  results  obtained  by  these  two  methods 
because the CBS method is designed for application to a 
single sample of data, whereas the linear-median method 
is applicable to a group of independent samples.
To apply the CBS algorithm to observations {xi,p}, 
i = 1, ⋅⋅⋅, 60, p = 1, ⋅⋅⋅, 300, we make the following 
adjustment. We calculate log2(xi,p) for all i and p, since 
the CBS method is designed for data in a nonlinear 
format. Then, for each fixed p, we calculate the median 
of {log2(xi,p)}, forming a new sequence. Finally, we 
apply the CBS method to this sequence. We justify 
this comparison with the following   argument: If there 
are common copy number alteration regions among 
the group of independent samples, the new sequence 
must  contain  the  information  on  shared  common 
regions. We consider the new sequence as if it were a 
single sample of data from a “patient”. Thus, if the 
information  of  a  shared  common  region  is  strong 
enough, the CBS method should be able to detect the 
region based on the data of the new sequence. We used 
the  default  parameters  in  our  application  of  the 
R package to the simulation data in this example.
Figure 3 shows the plot of the medians of {log2(xi,p)} 
and the estimate of log2(tp/2) (in red), obtained by the 
CBS method (top panel), and the plot of the   estimation 
of tp obtained by the linear-median method (bottom 
panel). We see that the linear-median method is able 
to detect all the changes in the copy number.
Comparing the plots in Figures 3, both approaches, 
the linear-median method and the CBS method, were 
able to detect all the longer regions of alternations. 
However, all the shorter regions of alterations, [151, 
152], [201, 202] and [203, 204], were missed by the 
CBS method. This indicates that the linear-median 
method  has  more  power  than  the  CBS  method  to 
detect shorter segments of alterations or narrow gaps 
between segments.
3.2. Application to real data
We applied the linear-median method to a subset of 
aCGH data from 39 well-studied lung cancer cell lines. 
Figure 3. Application of the CBS method to the sequence of the median of the logarithm of the ratios (top panel). The red bars show the values of 
the estimation of log2(tp/2). Application of the linear-median method to the data in Example 3 (bottom panel), showing the estimates of tp at each 
probe position.
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  Garnis  et  al14  are  available  for  downloading  from 
http://sigma.bccrc.ca/. For this study, we used data 
from only the subgroup with the largest sample size, 
that of non-small cell adenocarcinoma (NA), which 
included 18 samples.
As both the linear-median method and the cgh-
MCR method are designed for application to multiple 
aCGH data, the sample size is a critical issue. Data 
with more independent samples are able to provide 
more  information  on  the  commonalities  across  all 
samples.
Accurately identifying the locations of copy number 
aberrations has many important medical applications. 
As far as we know, the cghMCR method is one of the 
methods used to estimate the shared copy number for 
multiple aCGH data. Many other methods give an 
estimation of only the probability of gain/loss at each 
probe position.4,13
Information on the exact shared copy number(s) 
at each probe position is not available for the data we 
have analyzed (the NA data). Therefore, based on 
only the analytic outputs of the linear-median method 
and the cghMCR method, it is difficult for us to claim 
which method is better in terms of the accuracy of 
estimating the true copy numbers. As a result, we 
compared the similarities between the analytic out-
puts of the two methods and determined which method 
provides more information on the changes in the copy 
numbers in the NA data. As a reference for this com-
parison, we used the probability of gain/loss at each 
probe position that was reported by Shah et al.4
The total number of probe positions in the NA data 
(chromosome 9) is 1249. Recalling Model 4 in Sec-
tion 2.1, in order to estimate the shared copy num-
bers in a “test” DNA sequence, we need to know the 
parameter π. This type of information is also required 
for the cghMCR method. The value of π might be 
estimated  based  on  the  researcher’s  empirical 
  knowledge. For the NA data, empirical knowledge on 
the value of π is not available. Therefore, we applied 
the cghMCR method and the linear-median method 
to the data for different values of π, 0.2, 0.4, 0.6, 0.8 
and 1. Then we compared the results from both meth-
ods  and  also  compared  those  results  to  findings 
reported by Shah et al.4 We expected to find little 
  difference  in  the  results  obtained  from  the  three 
  methods. Shah et al found a loss of the shared copy 
number in a   significant portion of the NA data (see 
Figure 7 in their paper).4 However, for π = 0.4, 0.6, 
0.8 or 1, both the cghMCR method and the linear-
median method provided high proportions of neutral 
states, ie, where the shared copy number equals 2. 
Therefore, it is reasonable to use π = 0.2 when ana-
lyzing the NA data. We limit our report of the ana-
lytic results to the case where π = 0.2.
Combining  all  the  results  given  by  the  linear- 
median method and the cghMCR method for π = 0.2, 
0.4, 0.6, 0.8 and 1, we were able to identify a com-
mon trend in the outputs of the two methods for all 
probe positions as the value π moves from 1 to 0.2 
(data not shown). For the NA data, both the linear-
median method and the cghMCR method give neutral 
states to all probe positions when π is assigned as 1, 
with the exception of a few probe positions identified 
as  gain/loss  by  the  linear-median  method.  In  our 
empirical study of the NA data, if a probe position a 
is more likely to lose copy number(s), then the shared 
copy number estimation given by both methods will 
decrease as π moves from 1 to 0.2; if a probe position 
a is more likely to gain copy number(s), then the 
shared copy number estimation given by both meth-
ods  will  increase  as  π  moves  from  1  to  0.2.  One 
important phenomenon we observed from the outputs 
of the two methods is that once a probe position has 
been  identified  as  having  a  shared  copy  number 
change when π = π0, the observation remains the same 
for any π . π0. Comparing the results of the two 
methods, we found that the estimation of the shared 
copy number at each probe position given by the cgh-
MCR method is reluctant to change as the value of π 
decreases. In contrast, the linear-median method can 
show changes in the estimated shared copy number 
as π decreases. This may reflect the later detection of 
an aberration by the cghMCR method compared to 
the linear-median method when the true shared copy 
number at a probe position is gained/lost, and as the 
value of π decreases. Based on our analysis of the NA 
data, the linear-median method was able to report the 
estimated shared copy number at each probe posi-
tion; whereas the cghMCR method reported only the 
state of the shared copy number, ie, wether there was 
a gain, loss or no change (neutral state), in the shared 
copy number. To simplify the comparison between 
the results given by the two methods, we report only 
the gain, loss, or neutral states of the shared copy 
Lin et al
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states for both methods is given in Figure 4. In the 
plot, we use “1”, “0” and “-1” to indicate a shared 
copy number gain, neutrality, or loss, respectively. 
We summarize the results as follows.
From probe positions 1 to 500 and 1235 to 1249, 
both  the  cghMCR  method  and  the  linear-median 
method provide similar results, except for some iso-
lated prob positions. This is what we expect to find 
because our simulation studies demonstrated that the 
linear-median  method  can  identify  those  isolated 
regions.
From  probe  positions  501  to  1234,  the  results 
obtained from the linear-median method and the cgh-
MCR  method  are  quite  different.  The  cghMCR 
method claims that all the probe positions are neutral, 
in contrast to the findings of the linear-median method, 
which identifies gains/losses at these probe positions. 
One  possible  explanation  for  the  large  difference 
between the two sets of results in this prob region is 
that the π used in the estimation for this region may 
be too high. A lower value of π should be used to 
accurately  estimate  copy  numbers  in  this  interval. 
These results suggest that the parameter π might vary 
over  sequences  of  NA  data.  If  this  is  true,  then, 
  detecting  the  change  in  π  will  be  an  interesting 
  challenge for future studies.
Information on the true shared copy numbers for 
the NA data is not available; hence, we cannot be cer-
tain which method would best estimate the shared 
copy  number  variations  in  these  data.  However, 
through our comparison of the two methods and tak-
ing into account the results given by Shah et al4 we 
can claim that the linear-median method has some 
capability to reasonably estimate shared copy num-
bers in DNA sequences. As shown in our simulation 
studies, the linear-median method can easily identify 
isolated probe positions with shared copy number 
changes or short shared alternating segments. These 
changes are often missed by the cghMCR approach.
The 1249 probe sets we studied target the shared 
copy number status of 1262 genes present in the chro-
mosome 9.
In order to classify these genes as one of three gen-
eral categories, we performed a search of the OMIM 
database  (http://www.ncbi.nlm.nih.gov/omim).  The 
three categories we used were “not related to/unknown 
cancer  phenotype  (NR/U)”,  “cancer-related  pheno-
type, except for lung cancer (CR)”, and “lung cancer-
related phenotype (LCR)”. The results are presented 
in Tables 2 and 3. Identifying altered regions where 
important cancer-related genes are located aids the 
biological interpretation of our findings and works as 
an empirical form of validation. Detailed locations of 
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Figure 4. The output of the linear-median adjusted method is shown in red and that of the cghMCR method is in green.
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  presented  in  Supplementary  Appendix  B.  From 
Tables 2 and 3 we can see that the linear-median 
method is able to report more CR and LCR with copy 
number losses/gains than the cghMCR method.
We  were  able  to  find  additional  information  of 
interest from the output of the linear-median method. 
Focusing on the probe positions at which the   estimated 
shared  copy  number  given  by  the  linear-median 
method was ,1 or .3 when π = 0.2, we identified 
145 such probe positions out of 1249 (see Figure 5). 
Among those 145 probe positions, 22 probe positions 
Table 2. number of genes identified by the linear-median 
method (lM) and the cghMCR method in the regions of 
shared copy number aberrations with the status of copy 
number loss, neutrality or gain. nR/U is not cancer-related 
or unknown function phenotype, CR is cancer-related phe-
notype (except for lung cancer), and lCR is lung cancer-
related phenotype.
nR/U cR LcR Total
LM cgh 
McR
LM cgh 
McR
LM cgh 
McR
LM cgh 
McR
Losses 670 346 89 33 9 4 768 383
Neutral 342 758 35 103 3 9 380 870
Gains 100 8 13 1 1 0 114 9
1112 137 13
Table  3.  List  of  lung  cancer-related  genes  for  each 
  phenotypic group identified by the linear-median method 
(lM) and the cghMCR method.
LM cghMcR
Loss PSIP1, CDKN2A PSIP1, CDKN2A
TUSC1, iGFBPl1 TUSC1, iGFBPl1
TlE1, FRMD3
DAPK1, MiRlET7A1
PTPN3
Neutral PHF19, DAB2IP PHF19, DAB2IP
RPl12 RPl12, TlE1
FRMD3, DAPK1
MiRlET7A1, PTPn3
GAS1
Gain GAS1
showed an estimated copy number $4 or #-1. These 
results  provided  a  more  serious  warning  of  copy 
  number aberrations — a warning that was not obtained 
from the cghMCR method.
4. conclusion
We developed a new model for aCGH data analysis, 
the  linear-median  method,  which  estimates  shared 
copy numbers in DNA sequences. Using simulated 
data, we found the linear-median method to be more 
powerful  than  the  cghMCR  method  in  terms  of 
achieving a higher rate of true positives and a lower 
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Figure 5. The plot of the estimated copy numbers (,1 or .3) given by the linear-median method for π = 0.2.
Lin et al
240  Cancer Informatics 2010:9rate of false positives. In addition to estimating the 
common  gain/loss  of  chromosome  regions,  the 
  linear-median method estimates the number of DNA 
copies. In other words, analytic results produced by 
the linear-median method allow us to extract addi-
tional information on the tested DNA sequences. In 
particular, the linear-median method has the power to 
estimate  common  changes  that  appear  at  isolated 
  single probe positions or very short regions. The only 
drawback  of  the  linear-median  method  is  that  it 
ignores the dependency information in samples. How-
ever, based on our application of the proposed method 
to real data, we find that most information on shared 
copy  number  aberrations  can  be  captured  by  the 
  linear-median  method  using  only  the  information 
across independent samples.
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Appendix A
Use Monte Carlo method to indirectly show that the 
value of aE(Xp   )/{log [(2+a)/(2− a)] mXp   } is close to 1 
for a = 0.1, 0.2, ⋅⋅⋅, 1.9 and π = 0.1, 0.2, ⋅⋅⋅, 1.
The simulation is conducted as follows. For each 
triplet (a, π, tp), 5000 independent samples are simu-
lated from model
XX a
T
pp
p  (, ), π
ε
η
=
+
+ 2
,
where random variables Tp, ε and η are independent; 
Tp has a distribution such that P(Tp = tp) = π and 
P(Tp = 2) = 1 - π; ε and η have uniform distribution 
U(-a, a), a = 0.1, 0.2, 0.3, ⋅⋅⋅, 1.9 and π = 0.1, ⋅⋅⋅, 1 
with increments of 0.1 respectively; tp = 1, 2, ⋅⋅⋅, 9 
with increments of 1. The mean and median of Xp(a, π) 
are  estimated  by  its  sample  mean  Xa p(, ) π   and 
  sample median median(Xp)(a, π) respectively. Then 
aE(Xp(a,π))/{log [(2+a)/(2− a)]  mXp(a,π)}  is  esti-
mated and evaluated by
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and reported in Tables 1 and 2, which follow, where 
s2(π) is given within the parentheses.
The Monte Carlo simulation results clearly show 
that all the sample means m(π, tp) are close to 1 and 
the sample variance s2(π, tp) are close to 0. Therefore, 
it is reasonable to accept that aE(Xp(a,π))/{log [(2+a)/
(2− a)] mXp(a,π)}, for any a ∈ (0, 2), π ∈ (0, 1) and 
tp ∈ {l, ⋅⋅⋅, 9}.
Table s1. The values of m(π, tp) and s2(π, tp) (Part A).
π = 1
tp = 1 tp = 2 tp = 3 tp = 4 tp = 5
0.9988320 
(1.204417e-05)
0.9999922 
(6.722244e-06)
1.0006107 
(5.334313e-06)
0.9996400 
(1.261637e-05)
1.0010851 
(1.167334e-05)
tp = 6 tp = 7 tp = 8 tp = 9
0.9996429 
(1.231912e-06)
1.0007002 
(5.472384e-06)
0.9996422 
(5.472957e-06)
0.9995458 
(4.414939e-06)
π = 0.9
tp = 1 tp = 2 tp = 3 tp = 4 tp = 5
1.0234726 
(7.944477e-04)
0.9999251 
(3.122031e-06)
0.9945141 
(7.239544e-05)
0.9874093 
(2.153089e-04)
0.9815765 
(3.306295e-04)
tp = 6 tp = 7 tp = 8 tp = 9
0.9784618 
(4.723169e-04)
0.9754699 
(5.685863e-04)
0.9728850 
(5.824456e-04)
0.9690245 
(5.801032e-04)
(Continued)
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π = 0.8
tp = 1 tp = 2 tp = 3 tp = 4 tp = 5
1.0387630 
(2.886933e-03)
0.9996188 
(9.836780e-06)
0.9892445 
(2.590746e-04)
0.9765723 
(8.382101e-04)
0.9673282 
(1.415877e-03)
tp = 6 tp = 7 tp = 8 tp = 9
0.9586696 
(1.799211e-03)
0.9522338 
(2.116493e-03)
0.9460126 
(2.245196e-03)
0.9428445 
(2.510819e-03)
π = 0.7
tp = 1 tp = 2 tp = 3 tp = 4 tp = 5
1.0490667 
(5.548408e-03)
1.0001018 
(1.432224e-05)
0.9855943 
(5.197429e-04)
0.9663545 
(1.709809e-03)
0.9524253 2 
(2.958586e-03)
tp = 6 tp = 7 tp = 8 tp = 9
0.9407424 
(3.912353e-03)
0.930110 
(4.538055e-03)
0.9227174 
(5.050342e-03)
0.9165458 
(5.479345e-03)
π = 0.6
tp = 1 tp = 2 tp = 3 tp = 4 tp = 5
1.0488169 
(7.753325e-03)
1.0010726 
(6.911221e-06)
0.9854699 
(7.413494e-04)
0.9623178 
(2.893487e-03)
0.9414670 
(4.946303e-03)
tp = 6 tp = 7 tp = 8 tp = 9
0.9257995 
(6.682264e-03)
0.9128190 
(8.140030e-03)
0.9026656 
(9.115055e-03)
0.8949812 
(1.010583e-02)
Table s2. The values of m(π, tp) and s2(π, tp) (Part B).
π = 0.5
tp = 1 tp = 2 tp = 3 tp = 4 tp = 5
0.9976367 
(3.009497e-03)
1.0008558 
(3.751868e-06)
1.0051801 
(1.132037e-03)
1.0075940 
(8.828197e-03)
1.0563732 
(3.143084e-02)
tp = 6 tp = 7 tp = 8 tp = 9
1.0996647 
(5.681301e-02)
0.9949510 
(3.069008e-02)
1.0348440 
(5.681301e-02)
1.2778189 
(3.069008e-02)
π = 0.4
tp = 1 tp = 2 tp = 3 tp = 4 tp = 5
0.9689243 
(2.197164e-03)
1.0004657 
(8.269312e-06)
1.0224327 
(1.544194e-03)
1.0774329 
(1.112485e-02)
1.1533009 
(3.060863e-02)
tp = 6 tp = 7 tp = 8 tp = 9
1.2460811 
(5.815739e-02)
1.3484609 
(9.379170e-02)
1.4610660 
(1.286891e-01)
1.5757287 
(1.732840e-01)
π = 0.3
tp = 1 tp = 2 tp = 3 tp = 4 tp = 5
0.9690245 
(1.446965e-03)
1.0008585 
(3.876559e-06)
1.0242324 
(1.226318e-03)
1.0860159 
(6.909656e-03)
1.1647982 
(1.727091e-02)
tp = 6 tp = 7 tp = 8 tp = 9
1.2629289 
(2.912726e-02)
1.3679820 
(4.057614e-02)
1.4846238 
(5.020234e-02)
1.5987995 
(5.951541e-02)
(Continued)
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Figure s1. The plot of the mean of gains/losses obtained at each probe position using the cghMCR method.
Table s2. (Continued)
π = 0.2
tp = 1 tp = 2 tp = 3 tp = 4 tp = 5
0.9737273 
(6.463392e-04)
1.0001785 
(3.456922e-06)
1.0231539 
(5.653691e-04)
1.0743057 
(3.026114e-03)
1.1446959 
(6.303903e-03)
tp = 6 tp = 7 tp = 8 tp = 9
1.2239605 
(9.262918e-03)
1.3104238 
(1.097795e-02)
1.3991247 
(1.232603e-02)
1.4862704 
(1.325612e-02)
π = 0.1
tp = 1 tp = 2 tp = 3 tp = 4 tp = 5
0.9836251 
(1.448035e-04)
0.9996371 
(1.181245e-05)
1.0143460 
(1.537200e-04)
1.0458579 
(6.429722e-04)
1.0869769 
(1.166530e-03)
tp = 6 tp = 7 tp = 8 tp = 9
1.1335024 
(1.374409e-03)
1.1808455 
(1.518496e-03)
1.2294815 
(1.587512e-03)
1.2743215 
(1.669519e-03)
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The locations of the genes of NR/U, CR and LCR in 
non-small  cell  adenocarci-noma  (NA)  and  related 
references.
•  Probe positions from 1 to 295: A total of 200 genes 
are found in this region, 28 of them (14%) are 
genes related to cancer phenotype while 3 (1.5%) 
are  related  to  lung  cancer  phenotype.  All  LCR 
genes are located in chromosomal regions identi-
fied as losses by both methods (LM and cghMCR). 
The LCR genes located at this region are PSIP1, 
CDKN2A, and TUSC1. PSIP1 and CDKN2A, a 
well-known  lung  cancer  suppressor1  are  both 
located in a region frequently found deleted in lung 
cancer  patients.2  In  addition,  TUSC1  is  found 
mutated and silent in nonsmall cell lung carcinoma 
cell lines.3
•  Probe  positions  from  296  to  331:  A  total  of 
12 NR/U genes are found in this region.
•  Probe positions from 332 to 341: Only 3 genes are 
located in this region with one of them being clas-
sified as CR (ACO1). Both methods identify the 
region where this gene is located as loss.
•  Probe  positions  from  342  to  375:  A  total  of 
113 genes are located in this regions with 14 of 
them being classified as CR.
•  Probe  positions  from  376  to  500:  A  total  of 
171 genes are located in this region. Four of them 
are CR and only one (IGFBPL1, classified as loss 
by both methods) is classified as LCR. IGFBPL1 
has already been shown to be downregulated in 
lung tumor samples.4
•  Probe  positions  from  501  to  1234:  A  total  of 
744 genes are located in this region, 90 of them being 
classified  as  CR,  and  9  as  LCR.  The    cghMCR 
method does not identify any region containing LCR 
as altered. On the other hand, the LM method identi-
fies five of the LCR genes in chromosomal regions 
of  loss  (TLE1,  FRMD3,  DAPK1,  MIRLET7A1, 
PTPN3)  and,  consequently,  are  expected  to  have 
lower expression in lung tumor samples. In fact, 
TLE1 is frequently found altered in squamous cell 
carcinomas  and    adenocarcinomas5  while  FRMD3 
expression is usually silenced in primary nonsmall 
cell lung carcinomas.6 Likewise, mouse lung carci-
noma  clones  characterized  by  highly  aggressive 
metastatic behavior did not express Dapk1.7 Also, 
MIRLET7A1 and PTPN3 expressions are downreg-
ulated in lung cancer.8,9 The LM indeti-fies one gene 
located in a gain region (GAS1), and therefore, it is 
expected to be overexpressed in lung cancer samples. 
  Surprisingly, Gas1 expression is known by its capac-
ity  of    suppressing  metastasis  in  lung,10  therefore, 
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Figure s2. The plot of the mean of copy numbers obtained at each probe position using the linear-median method.
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lated epigenetically or it is a false positive iden-
tified by the LM method. Again, the cghMCR 
method does identifies this region as neutral. In 
addition, 3 genes are found by both methods in 
neutral regions (PHF19, DAB2IP, RPL12) and, 
therefore,  we  believe  that  their  regulation  is 
being performed by epigenetic factors. In fact, 
PHF19 mRNA is known to be overexpressed in 
lung cancers9 as well as methylation of the pro-
moter  of  DAB2IP  is  associated  with  the  lung 
cancer  phenotype.11  Likewise,  RPL12  splice 
variant are frequently found in human lung car-
cinoma cell.12
•  Probe positions from 1235 to 1249: A total of 
17 genes are located in this regions with only 
one of them (ABL1) being classified as CR and 
identified as a gain by both methods.
Appendix c
R code for the linear-median function
•  x is an n × T matrix, the elements of y are aCGH 
observations in linear format
•  n denotes the number of independent samples
•   T denotes the size of each individual sample
•  At any probe position p, if the true shared copy 
number is not 2, the probability of having copy 
number changed is “prob”
•  Function “Linear_Median” gives the estimate of 
shared copy number at each probe position.
Linear_Median = function(x,n,T,prob){
medianx = c()
for (i in 1:T){
medianx[i] = median(x[i,])
}
justx = c()
justx = 2*(medianx-1+prob)/prob
xx = c()
xx = floor(justx)
for(i in 1:T){
if (justx[i].= xx[i]+0.5)
xx[i] = xx[i]+1
}
xx
}
Figure s3. The plot of the median of copy numbers obtained at each probe position using the linear-median method.
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where n = 20.
n = 20 L-M cgh 
McR
L-M cgh 
McR
L-M cgh 
McR
π α = 0.5 α = 1 α = 1.5
0.2
TP 0.6382 0.0714 0.7568 0.0024 0.8096 0
(0.0496) (0.1101) (0.0406) (0.0188) (0.0414) (0)
FP 0.3785 0.0040 0.6549 2.83e-04 0.7657 0
(0.0384) (0.0154) (0.0384) (0.0041) (0.0357) (0)
0.4
TP 0.7849 0.6760 0.7696 0.0308 0.7616 0
(0.0429) (0.1830) (0.0413) (0.0779) (0.0453) (0)
FP 0.0861 0.0415 0.3827 0.0011 0.5611 0
(0.0248) (0.0302) (0.0402) (0.0081) (0.0408) (0)
0.6
TP 0.9503 0.9075 0.8708 0.2759 0.8013 0
(0.0227) (0.0224) (0.0359) (0.1129) (0.0410) (0)
FP 0.0122 2.58e-05 0.2000 0.0023 0.3905 0
(0.0090) (0.0004) (0.0310) (0.0114) (0.0419) (0)
0.8
TP 0.9966 0.9030 0.9451 0.3877 0.8677 0
(0.0060) (0.0206) (0.0204) (0.1308) (0.0331) (0)
FP 0.0013 0 0.0238 0 0.2617 0
(0.0028) (0) (0.0917) (0) (0.0358) (0)
1
TP 1 0.9490 0.9817 0.6542 0.9237 0
(0) (0.0147) (0.0147) (0.1561) (0.0287) (0)
FP 7.74e-05 0 0.04026 0 0.1667 0
(0.0007) (0) (0.0154) (0) (0.0314) (0)
Table s4. The true positive (TP) rates and false positive (FP) rates for the linear-median method and the cghMCR method, 
where n = 50.
n = 50 L-M cgh 
McR
L-M cgh 
McR
L-M cgh 
McR
π α = 0.5 α = 1 α = 1.5
0.2
TP 0.6309 0.02442 0.7147 0 0.7521 0
(0.0547) (0.0626) (0.0499) (0) (0.0455) (0)
FP 0.1712 6.45e-04 0.4866 0 0.6425 0
(0.0346) (0.0065) (0.0488) (0) (0.0437) (0)
0.4
TP 0.8895 0.6643 0.8574 0.0019 0.7975 0
(0.0347) (0.1542) (0.0357) (0.0109) (0.0420) (0)
FP 0.0089 0.0439 0.1737 0 0.3603 0
(0.0070) (0.0297) (0.0365) (0) (0.0416) (0)
0.6
TP 0.9949 0.9046 0.9581 0.2762 0.8926 0
(0.0072) (0.0149) (0.0212) (0.0842) (0.0358) (0)
FP 6.45e-05 0 0.0482 0 0.1814 0
(0.0006) (0) (0.0189) (0) (0.0364) (0)
(Continued)
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where n = 100.
n = 100 L-M cgh 
McR
L-M cgh 
McR
L-M cgh 
McR
π α = 0.5 α = 1 α = 1.5
0.2
TP 0.6771 0.0048 0.7438 0 0.7335 0
(0.0539) (0.0203) (0.0505) (0) (0.0461) (0)
FP 0.0561 0 0.3266 0 0.5146 0
(0.0187) (0) (0.0412) (0) (0.0381) (0)
0.4
TP 0.9566 0.6650 0.9299 0.0004 0.8718 0
(0.0233) (0.1317) (0.02653) (0.0030) (0.0341) (0)
FP 0.0003 0.0455 0.0578 0 0.2012 0
(0.0013) (0.0270) (0.0196) (0) (0.0340) (0)
0.6
TP 0.9998 0.9033 0.9920 02804 0.9556 0
(0.0015) (0.0108) (0.01010) (0.0706) (0.0239) (0)
FP 0 0 0.0065 0 0.0621 0
(0) (0) (0.0075) (0) (0.0224) (0)
0.8
TP 1 0.8956 0.9998 0.3345 0.9922 0
(0) (0.0087) (0.0015) (0.0193) (0.0099) (0)
FP 0 0 0.0003 0 0.0167 0
(0) (0) (0.0013) (0) (0.0125) (0)
1
TP 1 0.8971 0.9998 0.2263 0.9983 0
(0) (0.0177) (0.0015) (0.1156) (0.0044) (0)
FP 0 0 0.0003 0 0.0043 0
(0) (0) (0.0013) (0) (0.0056) (0)
Table s4. (Continued)
n = 50 L-M cgh 
McR
L-M cgh 
McR
L-M cgh 
McR
π a = 0.5 a = 1 a = 1.5
0.8
TP 1 0.8962 0.9912 0.3384 0.9545 0
(0) (0.0118) (0.0100) (0.0416) (0.0209) (0)
FP 0 0 0.0100 0 0.0826 0
(0) (0) (0.0082) (0) (0.0238) (0)
1
TP 1 0.9207 0.9992 0.4155 0.9848 0
(0) (0.0154) (0.0029) (0.1679) (0.0107) (0)
FP 0 0 0.0023 0 0.0348 0
(0) (0) (0.0038) (0) (0.0153) (0)
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